Survival benefits associated with surgery for advanced non–small cell lung cancer

ObjectiveOverall survival (OS) for advanced stage (IIIA-IV) non–small cell lung cancer (NSCLC) is highly variable, and retrospective data show a survival advantage for patients receiving therapeutic intent pulmonary resection. We hypothesized that this variability in OS can be modeled separately by stage to allow a personalized estimate of OS.MethodsIn a cohort of patients with advanced-stage NSCLC from the National Cancer Database, we assessed...